Perpetual Ltd lessened its stake in shares of Afya Limited (NASDAQ:AFYA – Free Report) by 56.2% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 66,288 shares of the company’s stock after selling 84,892 shares during the period. Perpetual Ltd owned 0.07% of Afya worth $1,034,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. State of Wyoming acquired a new stake in shares of Afya during the 2nd quarter worth $164,000. Militia Capital Partners LP bought a new stake in Afya during the second quarter worth about $71,000. Lazard Asset Management LLC grew its stake in Afya by 166.6% during the second quarter. Lazard Asset Management LLC now owns 18,463 shares of the company’s stock worth $329,000 after buying an additional 11,537 shares in the last quarter. Engineers Gate Manager LP bought a new position in Afya in the 2nd quarter valued at about $363,000. Finally, BNP Paribas Financial Markets raised its position in shares of Afya by 175.2% in the 2nd quarter. BNP Paribas Financial Markets now owns 25,511 shares of the company’s stock valued at $456,000 after buying an additional 16,241 shares in the last quarter. 88.02% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
AFYA has been the topic of a number of recent analyst reports. Wall Street Zen cut shares of Afya from a “strong-buy” rating to a “buy” rating in a research note on Saturday. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Afya in a report on Wednesday, October 8th. UBS Group raised Afya from a “neutral” rating to a “buy” rating and lowered their price target for the stock from $19.50 to $19.00 in a report on Monday, September 8th. Finally, JPMorgan Chase & Co. raised Afya from a “neutral” rating to an “overweight” rating and raised their price objective for the company from $23.50 to $24.50 in a research note on Monday, September 8th. Three research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, Afya currently has a consensus rating of “Moderate Buy” and an average target price of $18.75.
Afya Stock Down 0.5%
Shares of NASDAQ:AFYA opened at $14.56 on Monday. Afya Limited has a 52-week low of $13.47 and a 52-week high of $19.90. The company has a market capitalization of $1.36 billion, a PE ratio of 10.47, a price-to-earnings-growth ratio of 0.51 and a beta of 0.52. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.98 and a current ratio of 0.98. The company has a fifty day moving average of $14.65 and a 200-day moving average of $15.41.
Afya Profile
Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.
At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.
See Also
- Five stocks we like better than Afya
- I Shouldn’t Be Sending You This
- Wall Street Stock picker Names #1 Stock of 2026
- End of America update
- They Laughed at $30. They Won’t Laugh at $70.
- How Long Will $1M Last in Retirement?
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.
